1. Carlow, D. A., Kerbel, R. S., Feltis, J.T. and Elliott, B.E., 1985, “Enhanced expression of class I MHC gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma” J. Natl. Cancer Inst.,75: 291.
2. Due, C., Simonsen, M. and Olsson, L., 1986, “The MHC class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implication for the range of biological functions of histocompatibility antigens”, Proc. Natl. Acad. Sci. U.S.A., 83: 6007.
3. Eisenbach, L., Hollander, N., Greenfeld, L., Yakor, H., Segal, S. and Feldman, M., 1984, “The differential expression of H-2K versus H-2D antigens distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells”, Int. J. Cancer, 34: 567.
4. Falcioni, R., Kennel, S. J., Giacomini, P., Zupi, G. and Sacchi A., 1986, “Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice”, Cancer Res., 46: 5772.
5. Fidler, I. J., Gruys, E., Cifone, M.A., Barnes, Z. and Bucana, C., 1981, “demonstration of multiple phenotypic diversity in a murine melanoma of recent origin”, J. Natl. Cancer Inst., 67: 947.